抑癌基因結(jié)合蛋白ARID1B抗體 返回列表頁

英文名稱 ARID1B
中文名稱 抑癌基因結(jié)合蛋白ARID1B抗體
別    名 6A3 5; ARID 1B; ARID domain containing protein 1B; AT rich interactive domain 1B (SWI1 like); AT rich interactive domain 1B; AT rich interactive domain containing protein 1B; BAF 250b; BAF250b; BRG1 associated factor 250b; BRG1 binding protein; BRG1 binding protein ELD/OSA1; BRG1 binding protein hELD/OSA1; BRIGHT; DAN 15; DAN15; Eld (eyelid)/Osa protein; ELD/OSA1; hELD/OSA1; hOsa 2; hOsa2; KIAA1235; OSA 2; Osa homolog 2; OSA2; OTTHUMP00000040115; p250R; RP11 419L10.1.
抑癌基因結(jié)合蛋白ARID1B抗體
說 明 書 0.1ml  0.2ml  
研究領(lǐng)域 細(xì)胞生物  結(jié)合蛋白  表觀遺傳學(xué)  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Cow, Sheep, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 236kDa
細(xì)胞定位 細(xì)胞核 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human ARID1B
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產(chǎn)品介紹 background:
The SWI-SNF complex is involved in the activation of transcription via the remodeling of nucleosome structure in an ATP-dependent manner. Brm (also designated SNF2 alpha) and Brg-1 (also designated SNF2 beta) are the ATPase subunits of the mammalian SWI-SNF complex. Brm, Brg-1, Ini1 (integrase interactor 1, also designated SNF5), BAF155 (also designated SRG3) and BAF170 are thought to comprise the functional core of the SWI-SNF complex. Addition of Ini1, BAF155 and BAF170 to Brg-1 appears to increase remodeling activity. Other complex subunits, such as BAF250 (p270 or ARID 1A) and BAF250b(ARID1B), are thought to play regulatory roles.

Function:
ARID1B (AT-rich interactive domain-containing protein 1B) is a component of SWI/SNF chromatin remodeling complexes involved in transcriptional activation and repression of select genes by chromatin remodeling. It binds DNA non-specifically and alters DNA-nucleosome topology.

Subunit:
Component of SWI/SNF chromatin remodeling complexes, in some of which it can be mutually exclusive with ARID1A/BAF250A. Component of the BAF (SWI/SNF-A) complex, which includes at least actin (ACTB), ARID1A, ARID1B/BAF250, SMARCA2, SMARCA4/BRG1/BAF190A, ACTL6A/BAF53, ACTL6B/BAF53B, SMARCE1/BAF57, SMARCC1/BAF155, SMARCC2/BAF170, SMARCB1/SNF5/INI1, and one or more of SMARCD1/BAF60A, SMARCD2/BAF60B, or SMARCD3/BAF60C. In muscle cells, the BAF complex also contains DPF3. Component of the SWI/SNF-B (PBAF) complex, at least composed of SMARCA4/BRG1/BAF190A, SMARCB1/BAF47, ACTL6A/BAF53A or ACTL6B/BAF53B, SMARCE1/BAF57, SMARCD1/BAF60A, SMARCD2/BAF60B, perhaps SMARCD3/BAF60C, SMARCC1/BAF155, SMARCC2/BAF170, PB1/BAF180, ARID2/BAF200, ARID1A/BAF250A or ARID1B/BAF250B and actin. Component of a SWI/SNF-like EPAFb complex, at least composed of SMARCA4/BRG1/BAF190A, SMARCB1/BAF47, ACTL6A/BAF53A, SMARCE1/BAF57, SMARCD1/BAF60A, SMARCD2/BAF60B, SMARCC1/BAF155, SMARCC2/BAF170, ARID1B/BAF250B, MLLT1/ENL and actin. Component of a SWI/SNF-like complex containing ARID1A/BAF250A and ARID1B/BAF250B. Interacts through its C-terminus with SMARCA2/BRM/BAF190B and SMARCA4/BRG1/BAF190A. Interacts with SMARCC1/BAF155. Component of neural progenitors-specific chromatin remodeling complex (npBAF complex) composed of at least, ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C, SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, PHF10/BAF45A, ACTL6A/BAF53A and actin. Component of neuron-specific chromatin remodeling complex (nBAF complex) composed of at least, ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C, SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A, SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170, DPF1/BAF45B, DPF3/BAF45C, ACTL6B/BAF53B and actin (By similarity).

Subcellular Location:
Nuclear.

Tissue Specificity:
Widely expressed with high levels in heart, skeletal muscle and kidney.

DISEASE:
Defects in ARID1B are the cause of mental retardation autosomal dominant type 12 (MRD12) [MIM:614562]. A disorder characterized by significantly below average general inlectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. MRD12 patients present with moderate to severe psychomotor retardation, and most show evidence of muscular hypotonia. In many patients, expressive speech is more severely affected than receptive function. Additional common findings include short stature, abnormal head shape and low-set, posteriorly rotated, and abnormally shaped ears, downslanting palpebral fissures, a bulbous nasal tip, a thin upper lip, minor teeth anomalies, and brachydactyly or single palmar creases. Autistic features are uncommon.

Similarity:
Contains 1 ARID domain.

Database links:
UniProtKB/Swiss-Prot: Q8NFD5.2

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.xy-6081R PDGFRL血小板源性生長因子受體β樣蛋白抗體
xy-3341R Phospho-PLC beta3 (Ser1105)磷酸化磷酯酶Cβ3抗體
xy-3330R Phospho-PERK(Thr980)磷酸化蛋白激酶樣內(nèi)質(zhì)網(wǎng)激酶抗體
xy-3528R PFK26磷酸果糖激酶2抗體
xy-3331R Phospho-PFK2 (Ser467)磷酸化6磷酸果糖激酶2抗體
xy-3332R phospho-PI3 kinase p85 alpha + gamma (Tyr467 + Tyr199)磷酸化磷脂酰肌醇激酶抗體
xy-3333R Phospho-PKC alpha/beta II (Thr638/641)磷酸化蛋白激酶C α/β2抗體
xy-3531R PKC alpha蛋白激酶C α抗體
xy-3334R Phospho-PKM2 (Tyr105)磷酸化丙酮酸激酶M2抗體
xy-3335R Phospho-PKR (Thr446)磷酸化蛋白激酶R抗體
xy-3336R Phospho-PKR (Thr451)磷酸化蛋白激酶R抗體
xy-3337R Phospho-PKR (Thr446 + Thr451)磷酸化蛋白激酶R抗體
xy-3338R Phospho-PLCG2(Tyr1217)磷酸化磷酯酶Cγ2抗體
xy-3339R Phospho-PLC gamma 2 (Tyr759)磷酸化磷酯酶Cγ2抗體
xy-3533R PLCG 1磷酯酶Cγ1抗體
xy-3320R Phospho-PDGFRA(Tyr849)/PDGFRB(Tyr857)磷酸化血小板源性生長因子受體α/β抗體
xy-3321R Phospho-PDGF Receptor beta (Tyr1009)磷酸化血小板源性生長因子受體-B抗體
xy-3322R Phospho-PDGF Receptor beta (Tyr1021)磷酸化血小板源性生長因子受體-B抗體
xy-3323R Phospho-PDGF Receptor beta (Tyr740)磷酸化血小板源性生長因子受體-B抗體
xy-3324R Phospho-PDGF Receptor beta (Tyr751)磷酸化血小板源性生長因子受體-B抗體
xy-3303R Phospho-PDGF Receptor beta (Tyr771)磷酸化血小板源性生長因子受體-B抗體
xy-3325R Phospho-PAR4 (Thr163)磷酸化蛋白酶活化受體4抗體
xy-3523R PBKPDZ連接激酶/T-LAK細(xì)胞源蛋白激酶抗體
xy-3326R Phospho-PBK (Thr9)磷酸化PDZ連接激酶/T-LAK細(xì)胞源蛋白激酶抗體
xy-3327R Phospho-PDK1(Ser241)磷酸化3磷酸肌醇依賴性蛋白激酶1
xy-3524R PEA15星形膠質(zhì)細(xì)胞PEA15抗體
xy-6084R POU6F2轉(zhuǎn)錄因子RPF1抗體
xy-6083R PHAP1蛋白磷酸酶2A抑制劑1抗體